Ad is loading...
ABVC
Price
$0.54
Change
-$0.01 (-1.82%)
Updated
Nov 22, 02:39 PM (EDT)
MDXXF
Price
$0.21
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

ABVC vs MDXXF

Header iconABVC vs MDXXF Comparison
Open Charts ABVC vs MDXXFBanner chart's image
ABVC BioPharma
Price$0.54
Change-$0.01 (-1.82%)
Volume$200
CapitalizationN/A
PharmAla Biotech Holdings
Price$0.21
Change-$0.00 (-0.00%)
Volume$24.5K
CapitalizationN/A
ABVC vs MDXXF Comparison Chart
Loading...
ABVC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ABVC vs. MDXXF commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVC is a Hold and MDXXF is a Buy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (ABVC: $0.55 vs. MDXXF: $0.21)
Brand notoriety: ABVC and MDXXF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVC: 49% vs. MDXXF: 56%
Market capitalization -- ABVC: $6.73M vs. MDXXF: $19.32M
ABVC [@Biotechnology] is valued at $6.73M. MDXXF’s [@Biotechnology] market capitalization is $19.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVC’s FA Score shows that 1 FA rating(s) are green whileMDXXF’s FA Score has 0 green FA rating(s).

  • ABVC’s FA Score: 1 green, 4 red.
  • MDXXF’s FA Score: 0 green, 5 red.
According to our system of comparison, ABVC is a better buy in the long-term than MDXXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVC’s TA Score shows that 4 TA indicator(s) are bullish.

  • ABVC’s TA Score: 4 bullish, 6 bearish.

Price Growth

ABVC (@Biotechnology) experienced а -0.20% price change this week, while MDXXF (@Biotechnology) price change was +1.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.98%, and the average quarterly price growth was +4.01%.

Reported Earning Dates

ABVC is expected to report earnings on Nov 13, 2023.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDXXF($19.3M) has a higher market cap than ABVC($6.73M). MDXXF YTD gains are higher at: 558.228 vs. ABVC (-52.595).
ABVCMDXXFABVC / MDXXF
Capitalization6.73M19.3M35%
EBITDA-6.36MN/A-
Gain YTD-52.595558.228-9%
P/E RatioN/AN/A-
Revenue510KN/A-
Total Cash208KN/A-
Total Debt2.33MN/A-
FUNDAMENTALS RATINGS
ABVC: Fundamental Ratings
ABVC
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABVC
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
74%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
ABVC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KNGZ34.450.49
+1.43%
FirstTrust S&P500 DvrsDiv AristocratsETF
FIAX19.370.08
+0.42%
Nicholas Fixed Income Alternative ETF
YYY12.100.05
+0.41%
Amplify High Income ETF
LITP8.460.03
+0.36%
Sprott Lithium Miners ETF
DXJ109.14-0.16
-0.15%
WisdomTree Japan Hedged Equity ETF

ABVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVC has been loosely correlated with KNSA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVC jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVC
1D Price
Change %
ABVC100%
-3.08%
KNSA - ABVC
40%
Loosely correlated
-0.57%
MRSN - ABVC
33%
Loosely correlated
-10.81%
MLEC - ABVC
31%
Poorly correlated
-0.47%
FULC - ABVC
27%
Poorly correlated
-0.67%
MDXXF - ABVC
25%
Poorly correlated
-9.90%
More

MDXXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXXF has been loosely correlated with NICXF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXXF jumps, then NICXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXXF
1D Price
Change %
MDXXF100%
-9.90%
NICXF - MDXXF
46%
Loosely correlated
N/A
ABVC - MDXXF
25%
Poorly correlated
-3.08%
ZIVO - MDXXF
23%
Poorly correlated
+0.19%
KNSA - MDXXF
20%
Poorly correlated
-0.57%
VYGR - MDXXF
20%
Poorly correlated
+1.31%
More